Medpace Holdings (MEDP) Earnings Analysis
Medpace Holdings (MEDP) next reports earnings on 2026-10-28, consensus EPS 4.22 USD. Last quarter (2026-07-22) it beat with EPS 4.25 USD vs 3.98 USD est (+6.8%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 30.37.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MEDP next report earnings?
| Next earnings date | 2026-10-28 |
|---|---|
| Consensus EPS estimate | 4.22 USD |
| Revenue estimate | 0.69B |
MEDP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-22 | 4.25 USD | 3.98 USD | +6.8% | Beat |
| 2026-04-22 | 4.28 USD | 3.92 USD | +9.2% | Beat |
| 2026-02-09 | 4.67 USD | 4.19 USD | +11.5% | Beat |
| 2025-10-22 | 3.86 USD | 3.53 USD | +9.3% | Beat |
| 2025-07-21 | 3.1 USD | 2.98 USD | +4% | Beat |
| 2025-04-21 | 3.67 USD | 3.06 USD | +19.9% | Beat |
| 2025-02-10 | 3.67 USD | 2.96 USD | +24% | Beat |
| 2024-10-21 | 3.01 USD | 2.78 USD | +8.3% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
MEDP valuation and analyst view
| Trailing P/E | 30.37 |
|---|---|
| Trailing EPS | 17.363 USD |
| Price / book | 34.46 |
| Dividend yield | 0.00% |
| Market cap | 15.28B |
| Analyst consensus | Hold (4 buy / 14 hold / 1 sell) |
| Avg price target | 499.25 USD |
Related research pages
Frequently asked questions
When is Medpace Holdings (MEDP)'s next earnings date?
Medpace Holdings is next scheduled to report on 2026-10-28, with a consensus EPS estimate of 4.22 USD and revenue estimate of 0.69B.
Did MEDP beat earnings last quarter?
In its 2026-07-22 report, MEDP posted EPS of 4.25 USD versus a 3.98 USD estimate — a beat of 6.8%.
What is MEDP's earnings track record?
Over the last 8 reported quarters with consensus data, MEDP beat estimates 8 times (100%).
What is MEDP's current P/E ratio and EPS?
MEDP trades at a trailing P/E of 30.37 on trailing EPS of 17.362583015402006 USD.
What do analysts rate MEDP?
Analyst consensus is "Hold" across 19 ratings (0 strong buy, 4 buy, 14 hold, 1 sell, 0 strong sell). Average 12-month price target: 499.25 USD.